Empromptu AI launches Alchemy, a no-code platform for building self-learning business AI applications
By
Jordan Hanson
Summary
Empromptu AI introduces Alchemy, a platform that enables businesses to build full-stack, AI-native applications without coding. The tool uses a conversational builder and intelligent agents for data ingestion, logic, and deployment, aiming to create AI that learns how a business operates rather than just generic workflows. The company argues that using the same frontier models as everyone else creates no lasting competitive advantage.
Source
Key quotes
· 3 pulledWe built Empromptu AI's Alchemy because we believe the next phase of AI is not just building apps faster.
It is building AI that learns how your business works.
But if everyone is using the same intelligence, no one is differentiated for long.
You might also wanna read
Alchemy Launches AgentCard: A Virtual Payment Layer for AI Agent Commerce
Alchemy's AgentCard is a new payment product designed for AI agents, enabling autonomous software to make online purchases. It functions as
Emdash: Open-Source Agentic Development Environment for Running Multiple Coding AI Agents in Parallel
Emdash is an open-source Agentic Development Environment (ADE) that enables developers to run multiple coding AI agents in parallel, each is
Boomi expands enterprise AI platform amid persistent business skepticism about AI readiness
Boomi announced an expansion of its enterprise platform to help bring AI agents from pilot projects to production-scale operations. However,
Building an Enterprise Context Layer with Minimal Code: A Contrarian Approach to Enterprise AI
The article presents a contrarian view on enterprise AI solutions, arguing that building an 'Enterprise Context Layer' - a central intellige
Emergent - Build Apps with AI
Vercel's Agent Stack: A Unified Framework for Building Production-Grade AI Agents
Vercel introduces the Agent Stack, a comprehensive framework for building production-grade AI agents. The article explains that every AI age

Comments
Sign in to join the conversation.
No comments yet. Be the first.